NEW YORK, April 19, 2022 (GLOBE NEWSWIRE) — Eyenovia, Inc. (NASDAQ: EYEN), an ophthalmic pharmaceutical technology company developing a pipeline of microdose array print (MAP™) therapeutics, today announced that the Company will present an ePoster at the American Society of Cataract and Refractive Surgery Annual Meeting, which is being held April 23-26 in Washington, D.C.
Details of the ePoster presentation are as follows:
Poster Title: Evaluation of Two Mydriatic Dosing Regimens Delivered by MICRO-Array Print Technology for Comparison of Pupil Dilation SPEED
